Judith L Swain Lexicon Pharmaceuticals, Inc. (LXRX) insider trading activity

LXRX Quotes by TradingView

Judith L Swain is Director of LEXICON PHARMACEUTICALS, INC.. Currently has a direct ownership of 85,174 shares of LXRX, which is worth approximately $102,208. The most recent transaction as insider was on May 13, 2025, when has been sold 36,810 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 85.2K
76.11% 3M change
76.11% 12M change
Total Value Held $102,208

Judith L Swain Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 13 2025
BUY
Exercise of conversion of derivative security
-
36,810 Added 30.18%
85,174 Common Stock
Apr 28 2024
BUY
Exercise of conversion of derivative security
-
8,032 Added 14.24%
48,364 Common Stock
May 21 2023
BUY
Exercise of conversion of derivative security
-
9,302 Added 18.74%
40,332 Common Stock
Apr 30 2022
BUY
Exercise of conversion of derivative security
-
4,024 Added 11.48%
31,030 Common Stock
Apr 24 2021
BUY
Exercise of conversion of derivative security
-
10,638 Added 28.26%
27,006 Common Stock

Also insider at

RXDX
Prometheus Biosciences, Inc. Healthcare
Director
JLS

Judith L Swain

Director
San Diego, CA

Track Institutional and Insider Activities on LXRX

Follow LEXICON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LXRX shares.

Notify only if

Insider Trading

Get notified when an Lexicon Pharmaceuticals, Inc. insider buys or sells LXRX shares.

Notify only if

News

Receive news related to LEXICON PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LXRX